Dosing control device for internal treatment with external application

Abstract

The application discloses a drug administration control device for internal disease treatment by external administration. The device comprises the following steps: administering drugs in a non-invasive manner to penetrate the skin to achieve internal disease treatment by external administration; determining drug administration disease characteristic data; determining drug administration characteristic data including drug administration meridian position characteristic data and drug administration data according to the drug administration disease characteristic data, so that the drug administration drug is administered through the meridian between the drug administration meridian position and the corresponding position of the disease to be treated; controlling the drug administration unit to provide the power of the drug penetration skin to perform skin administration at the drug administration meridian position according to the drug administration characteristic data; and determining the skin administration administration position and the drug administration drug according to the disease to be treated, so as to solve the problem that the drug administration process is not accurate in the prior art, and realize the technical effects of improving the drug administration accuracy and the drug administration efficiency.

Description

Technical Field

[0001] This application relates to the field of intelligent healthcare, and more specifically, to a drug delivery control device for treating internal diseases externally. Background Technology

[0002] Drug therapy is a common treatment method. The absorption of drugs has a significant impact on the treatment effect. In the current technology, drugs are administered through various methods, including oral administration, injection, patch application, and fumigation. The invasive drug administration process of the above methods has high requirements for the drugs, while the non-invasive drug administration process has the problem of inaccurate drug delivery, resulting in a low drug absorption rate.

[0003] Therefore, existing drug delivery devices suffer from inaccurate drug delivery during the drug delivery process. Summary of the Invention

[0004] The main objective of this application is to provide a drug delivery control device for treating internal diseases externally, in order to solve the problem of inaccurate drug delivery in existing drug delivery devices, improve drug delivery accuracy, and thus achieve the technical effect of improving drug delivery efficiency during the drug delivery process.

[0005] To achieve the above objectives, a first aspect of this application proposes a drug delivery control method for treating internal diseases externally, used to control the drug to be delivered non-invasively through the skin to achieve drug delivery therapy for treating internal diseases externally, applied in a drug delivery device equipped with a drug delivery unit, the drug delivery control method comprising:

[0006] Determine the disease characteristic data for drug administration, wherein the disease characteristic data for drug administration is characteristic data used to represent the disease to be treated by the drug;

[0007] Based on the disease-specific characteristic data, drug administration characteristic data is determined, wherein the drug administration characteristic data includes drug administration meridian location characteristic data and drug administration data, so that the drug is administered through the meridian between the drug administration meridian location and the location corresponding to the disease to be treated; and

[0008] Based on the drug delivery characteristic data, the drug delivery unit is controlled to provide the power for drug penetration and skin delivery at the drug delivery meridian location.

[0009] Optionally, determining the drug administration characteristic data based on the drug administration disease characteristic data includes:

[0010] The drug administration disease characteristic data is identified to obtain drug administration meridian characteristic data, wherein the drug administration meridian characteristic data is used to represent the meridian data corresponding to the treatment of the disease to be treated;

[0011] Based on the drug delivery meridian characteristic data, the drug delivery meridian location characteristic data is determined, wherein the drug delivery meridian location characteristic data is data used to represent the drug delivery location;

[0012] Match the drug administration data corresponding to the disease characteristic data in the preset drug administration database, wherein the drug administration data is data representing the drug to be administered; and

[0013] The drug administration feature data is obtained by performing drug administration feature generation processing on the drug administration meridian location feature data and the drug administration data.

[0014] Optionally, the drug administration disease characteristic data is identified to obtain drug administration meridian characteristic data, including:

[0015] Traverse the preset meridian drug delivery database, determine whether there is drug delivery meridian feature data corresponding to the drug delivery disease feature data in the preset meridian drug delivery database, and if there is, obtain the drug delivery meridian feature data;

[0016] If not, the disease-specific characteristic data for drug administration are identified to obtain a disease-specific MRI image, wherein the disease-specific MRI image is an MRI image representing the disease to be treated with the drug; and

[0017] The meridian feature extraction process based on image segmentation and recognition is performed on the MRI images of the disease to obtain the meridian feature data for drug administration.

[0018] Optionally, controlling the drug delivery unit to provide the power for drug penetration and skin delivery at the drug delivery meridian location based on the drug delivery characteristic data includes:

[0019] The drug administration characteristic data is identified to obtain the drug administration meridian location characteristic data and the drug administration data;

[0020] Matching drug delivery control feature data corresponding to the drug delivery meridian location feature data and the drug delivery data in a preset drug delivery database; the drug delivery control feature data is data representing the dynamics of controlling drug penetration through the skin for dermal drug delivery; and

[0021] At the drug delivery meridian location corresponding to the drug delivery meridian location feature data, the drug delivery unit carries the drug delivery drug corresponding to the drug delivery drug data, and controls the drug delivery unit to be fixed to the skin and provides the power for drug to penetrate the skin for drug delivery according to the drug delivery control feature data.

[0022] Optionally, controlling the fixation of the drug delivery unit to the skin and providing the power for drug penetration and administration based on the drug delivery control feature data includes:

[0023] Based on the drug delivery control characteristic data, drug delivery control parameters for skin administration are determined, wherein the control parameters include a first control parameter and a second control parameter, one of the first control parameter and the second control parameter is a pressure control parameter, and the other of the first control parameter and the second control parameter is a temperature control parameter; and

[0024] The pressure difference for skin administration is controlled by the pressure control parameters and the temperature control parameters, wherein the pressure difference is the pressure difference for drug delivery through the skin.

[0025] Optionally, the drug delivery device includes a first drug delivery unit and a second drug delivery unit. Controlling the drug delivery unit to provide the power for drug penetration and skin delivery at the drug delivery meridian location based on the drug delivery characteristic data includes:

[0026] The drug administration characteristic data is identified to obtain first drug administration characteristic data and second drug administration characteristic data, wherein the first drug administration characteristic data is drug administration characteristic data used to control the first drug administration unit to perform skin drug administration, and the second drug administration characteristic data is drug administration characteristic data used to control the second drug administration unit to perform skin drug administration;

[0027] The location of the first drug administration meridian is obtained by identifying the first drug administration characteristic data;

[0028] The second drug administration characteristic data is identified to obtain the location of the second drug administration meridian;

[0029] Based on the first drug delivery characteristic data, the first drug delivery unit is controlled to provide the power for drug penetration and skin delivery at the first drug delivery meridian location; and

[0030] Based on the second drug delivery characteristic data, the second drug delivery unit is controlled to provide the power for drug penetration and skin delivery at the second drug delivery meridian location.

[0031] According to a second aspect of this application, a skin drug delivery control device is provided for controlling the delivery of a drug in a non-invasive, skin-penetrating manner to achieve drug delivery therapy for treating internal diseases from the outside, and is applied in a drug delivery device provided with a drug delivery unit, the drug delivery control device comprising:

[0032] The disease identification module is used to identify the disease characteristics data for drug administration, wherein the disease characteristics data are characteristic data used to represent the disease to be treated by the drug administration.

[0033] The drug administration determination module determines drug administration characteristic data based on the disease characteristic data, wherein the drug administration characteristic data includes drug administration meridian location characteristic data and drug administration data, so that the drug is administered through the meridian between the drug administration meridian location and the location corresponding to the disease to be treated; and

[0034] The drug delivery control module controls the drug delivery unit to provide the power for drug penetration and skin delivery at the drug delivery meridian location based on the drug delivery characteristic data.

[0035] Optionally, in the drug delivery control device according to claim 1, the drug delivery determination module includes:

[0036] The disease identification module is used to identify the disease characteristic data of the drug administration and obtain the drug administration meridian characteristic data, wherein the drug administration meridian characteristic data is the meridian data used to represent the treatment of the disease to be treated;

[0037] The drug administration location determination module is used to determine drug administration meridian location feature data based on the drug administration meridian feature data, wherein the drug administration meridian location feature data is data used to represent the drug administration location;

[0038] A drug determination module is used to match drug data corresponding to the disease characteristic data in a preset drug administration database, wherein the drug data is data representing the drug to be administered; and

[0039] The drug administration feature determination module is used to perform drug administration feature generation processing on the drug administration meridian location feature data and the drug administration data to obtain the drug administration feature data.

[0040] According to a third aspect of this application, a computer-readable storage medium is provided, the computer-readable storage medium storing computer instructions for causing the computer to perform the above-described skin drug delivery control method.

[0041] According to a fourth aspect of this application, an electronic device is provided, comprising: at least one processor; and a memory communicatively connected to the at least one processor; wherein the memory stores a computer program executable by the at least one processor, the computer program being executed by the at least one processor to cause the at least one processor to perform the above-described skin drug delivery control method.

[0042] The technical solutions provided by the embodiments of this application may include the following beneficial effects:

[0043] In this application, drug administration is achieved through non-invasive skin penetration to treat internal diseases externally. Disease characteristic data is determined, and based on this data, drug administration characteristic data, including meridian location characteristics and drug data, is established. The drug administration unit is then controlled to provide the necessary power for drug penetration at the meridian location. By determining the drug administration location and drug based on the disease to be treated, the inaccuracy of drug administration in existing technologies is solved, achieving improved accuracy and efficiency. Attached Figure Description

[0044] The accompanying drawings, which form part of this application, are used to provide a further understanding of the application and to make other features, objects, and advantages of the application more apparent. The illustrative embodiments and descriptions of this application are used to explain the application and do not constitute an undue limitation of the application. In the drawings:

[0045] Figure 1 A flowchart of a skin drug delivery control method provided in this application;

[0046] Figure 2 A flowchart of a skin drug delivery control method provided in this application;

[0047] Figure 3 A flowchart of a skin drug delivery control method provided in this application;

[0048] Figure 4 This is a schematic diagram of the structure of a skin drug delivery control device provided in this application;

[0049] Figure 5 This is a schematic diagram of another skin drug delivery control device provided in this application. Detailed Implementation

[0050] To enable those skilled in the art to better understand the present application, the technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present application, and not all embodiments. Based on the embodiments in the present application, all other embodiments obtained by those of ordinary skill in the art without creative effort should fall within the scope of protection of the present application.

[0051] It should be noted that the terms "first," "second," etc., in the specification, claims, and accompanying drawings of this application are used to distinguish similar objects and are not necessarily used to describe a specific order or sequence. It should be understood that such data can be interchanged where appropriate for the embodiments of this application described herein. Furthermore, the terms "comprising" and "having," and any variations thereof, are intended to cover non-exclusive inclusion; for example, a process, method, system, product, or apparatus that comprises a series of steps or units is not necessarily limited to those steps or units explicitly listed, but may include other steps or units not explicitly listed or inherent to such processes, methods, products, or apparatus.

[0052] In this application, the terms "upper," "lower," "left," "right," "front," "rear," "top," "bottom," "inner," "outer," "middle," "vertical," "horizontal," "lateral," and "longitudinal" indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings. These terms are primarily for the purpose of better describing this application and its embodiments, and are not intended to limit the indicated device, element, or component to having a specific orientation, or to be constructed and operated in a specific orientation.

[0053] Furthermore, in addition to indicating location or positional relationship, some of the aforementioned terms may also have other meanings. For example, the term "above" may also be used in some cases to indicate a certain dependency or connection relationship. Those skilled in the art can understand the specific meaning of these terms in this application based on the specific circumstances.

[0054] Furthermore, the terms "installation," "setup," "equipped with," "connection," "linked," and "socketing" should be interpreted broadly. For example, "connection" can be a fixed connection, a detachable connection, or an integral structure; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium, or an internal connection between two devices, components, or parts. Those skilled in the art can understand the specific meaning of the above terms in this application according to the specific circumstances.

[0055] This application provides a skin drug delivery control method for controlling drug delivery via non-invasive skin penetration to achieve external treatment of internal diseases. This method is applied to a drug delivery device equipped with a drug delivery unit. During drug delivery, the drug delivery unit is fixed to the skin, providing the power for non-invasive drug penetration to the lesion site within the body, thus constructing a drug delivery channel and achieving external treatment of internal diseases through skin delivery. For example, for liver diseases, the drug delivery unit controls non-invasive drug penetration through the skin, establishing a drug delivery channel from the skin to the liver. The drug penetrates the skin through this channel to the liver, achieving treatment of liver diseases through skin delivery. Since the liver is an internal organ, treating liver diseases through skin delivery achieves external treatment of internal diseases.

[0056] Figure 1 A flowchart of a skin drug delivery control method provided in this application is shown below. Figure 1 As shown, the method includes:

[0057] S101: Determine the characteristic data of the diseases for which medication is administered;

[0058] Drug-specific disease characteristic data refers to the characteristic data used to represent the disease to be treated by the drug. Drug-specific disease characteristic data is data obtained through human-computer interaction to describe the disease to be treated by the drug. It includes different forms of drug-specific disease characteristic data obtained based on human-computer interaction, such as medical records, disease images (such as CT images, tongue images, eye images, etc.), and voice (such as voice description of symptoms). By acquiring different forms of drug-specific disease characteristic data, the accuracy of the description of the disease to be treated by the drug can be improved, so as to improve the efficiency of drug administration when administering drugs according to drug-specific disease characteristic data.

[0059] Drug-related disease characteristic data can also be symptom / sign, which is used to describe the abnormalities that occur after a patient becomes ill. This includes data obtained through human interaction to describe symptoms and signs, such as data on symptoms and signs in voice, text, or document form.

[0060] S102: Determine drug administration characteristic data based on the disease characteristic data of the drug administration;

[0061] The drug administration characteristic data includes drug delivery meridian location characteristic data and drug delivery data, so that the drug can be delivered through the meridian between the drug delivery meridian location and the corresponding location of the symptom to be treated. When administering drugs through the skin, the drug delivery location and the drug can be determined based on the drug administration characteristic data to improve the accuracy of drug delivery.

[0062] Figure 2 A flowchart of a skin drug delivery control method provided in this application is shown below. Figure 2 As shown, the method includes:

[0063] S201: Identify the characteristic data of the diseases treated with the drug and obtain the characteristic data of the meridians through which the drug is administered;

[0064] The meridian characteristic data for drug administration refers to the meridian data corresponding to the disease to be treated. In Traditional Chinese Medicine (TCM), meridians refer to the pathways through which Qi and blood circulate in the human body. Research has found that tissue fluid circulation is widespread in the human body, forming a tissue fluid transport network throughout the body. The tissue fluid transport pathway is closely related to the distribution of acupoints. The meridian characteristic data for drug administration refers to the relevant meridians at the lesion location of the disease to be treated, and the TCM meridians corresponding to the tissue fluid circulation at the lesion location. For example, facial paralysis is a disease caused by facial nerve palsy or facial nerve damage, belonging to the neurological department. The meridian corresponding to facial paralysis is the Governing Vessel (Du Mai). The Governing Vessel runs along the midline of the back, and its meridians intersect with the three Yang meridians of the hands and feet and the Yang Wei Meridian multiple times. It governs all the Yang meridians in the body. The Governing Vessel runs along the spine and ascends to the brain.

[0065] Traverse the preset meridian drug administration database to determine whether there is drug administration meridian feature data corresponding to the drug administration disease feature data in the preset meridian drug administration database. If it exists, obtain the drug administration meridian feature data; if it does not exist, identify the drug administration disease feature data to obtain the disease MRI image, where the disease MRI image is an MRI image used to represent the disease to be treated by the drug; perform meridian feature extraction processing based on image segmentation and recognition on the disease MRI image to obtain the drug administration meridian feature data.

[0066] The pre-set meridian drug delivery database establishes a mapping relationship between diseases and drug delivery meridians. The same disease can correspond to a single meridian or multiple meridians. For example, ascites can be treated via the Taiyang Bladder Meridian; lung diseases correspond to the Lung Meridian and can be treated via its upstream or downstream channels. If the pre-set meridian drug delivery database does not have a mapping relationship between the disease to be treated and the corresponding drug delivery meridian, the meridian feature data is extracted and processed from the MRI image of the disease to be treated to obtain the drug delivery meridian feature data.

[0067] The process of extracting meridian features from disease-specific MRI images based on image segmentation and recognition includes: performing image segmentation and recognition on disease-specific MRI images to obtain the location of lesions and the corresponding tissue fluid circulation data in the MRI images; matching the tissue fluid circulation data with meridians including the twelve meridians and the eight extraordinary meridians to obtain meridian feature data for drug administration.

[0068] S202: Determine the location characteristics of the drug delivery meridian based on the drug delivery meridian characteristic data;

[0069] The drug administration meridian location feature data is used to represent the drug administration location. This data describes the location of acupoints corresponding to the drug administration location. Based on the mapping relationship between acupoints and meridians, and according to the drug administration meridian feature data and the disease-specific feature data, the acupoints for dermal drug administration are determined. Since the meridian corresponding to the disease to be treated can be a single meridian or multiple meridians, the drug administration meridian feature data is identified. When the meridian corresponding to the disease to be treated is identified as a single meridian, the acupoints corresponding to that single meridian are determined based on the single meridian and the treatment strategy for the disease. For example, ascites can be treated by administering drugs through the Taiyang Bladder Meridian. Based on the multiple acupoints corresponding to the Taiyang Bladder Meridian and the diuretic treatment strategy for ascites, the acupoints belonging to the Taiyang Bladder Meridian, namely the bilateral Liver Shu and bilateral Kidney Shu, are determined for drug administration. When multiple meridians are identified as corresponding to a symptom, the acupoints for drug administration are determined based on the upstream and downstream relationships and intersections between these meridians, combined with the treatment strategy for the symptom. For example, in the case of lung diseases, drug administration can be performed through the Lung Meridian, its upstream and downstream meridians. Based on the Lung Meridian, its upstream and downstream meridians, and the treatment strategy for the lung disease, multiple acupoints located on these meridians are identified, and drug administration is performed at these acupoints. Determining the acupoints for dermal drug administration through the drug administration meridians improves the accuracy of drug delivery.

[0070] S203: Match the drug data corresponding to the disease characteristics data in the preset drug administration database;

[0071] Drug administration data refers to data representing the drugs to be administered. The determination of drug administration data is based on disease characteristic data, and includes data describing the type and dosage of the drug used to treat the disease. Determining drug administration data also includes: determining drug administration data based on meridian location characteristic data and disease characteristic data, whereby drug administration data represents the type and dosage of the drug at different administration locations.

[0072] S204: Perform drug administration feature generation processing on the drug administration meridian location feature data and drug administration data to obtain drug administration feature data.

[0073] S103: Based on the drug delivery characteristic data, control the drug delivery unit to provide the power for drug penetration and skin delivery at the drug delivery meridian location.

[0074] Figure 3 A flowchart of a skin drug delivery control method provided in this application is shown below. Figure 3 As shown, the method includes:

[0075] S301: Identify drug administration characteristic data to obtain drug administration meridian location characteristic data and drug administration data;

[0076] Drug administration data also includes drug characteristic data, which is used to represent the characteristics of the drug administration, including data representing the drug components and drug structure. For example, the components of the drug administration can be single-component or multi-component drugs, and the structure of the drug administration can be solid drugs, liquid drugs, or gaseous drugs.

[0077] S302: Match the drug administration control feature data corresponding to the drug administration meridian location feature data and the drug administration data in the preset drug administration database;

[0078] Drug administration control feature data represents the dynamics of drug penetration through the skin for dermal drug delivery. Drug administration meridian location feature data represents the acupoint location for dermal drug delivery. Due to differences in the skin, corresponding acupoints, and corresponding lesion locations at the drug administration location corresponding to the drug administration meridian location feature data, location-based drug administration control feature data is matched with the drug administration control feature data, and drug administration control feature data is matched with the drug administration data. The aforementioned drug administration control feature data is determined based on the location-based drug administration control feature data and the drug administration control feature data. Drug administration control feature data is used to control the parameters of the drug delivery unit during drug delivery, including drug administration temperature and drug administration pressure, to create a pressure difference based on the drug administration temperature and drug administration pressure for dermal drug penetration.

[0079] S303: At the drug delivery meridian location corresponding to the drug delivery meridian location feature data, the drug delivery unit carries the drug delivery data corresponding to the drug delivery data, and controls the drug delivery unit to be fixed to the skin according to the drug delivery control feature data and provides the power for the drug to penetrate the skin for drug delivery.

[0080] In another optional embodiment of this application, a skin drug delivery control method is provided, the method comprising:

[0081] Based on the drug delivery control characteristic data, drug delivery control parameters for skin drug delivery are determined, wherein the control parameters include a first control parameter and a second control parameter, one of the first control parameter and the second control parameter is a pressure control parameter, and the other of the first control parameter and the second control parameter is a temperature control parameter; the pressure difference for skin drug delivery is controlled by the pressure control parameter and the temperature control parameter, and the pressure difference is the pressure difference for drug delivery through skin penetration.

[0082] When controlling skin drug delivery, drug delivery characteristic data is determined based on disease characteristics. Different drug delivery sites and drugs are then determined based on the drug delivery characteristic data. The expression for the scheme of treating internal diseases externally through skin drug delivery is: S = c(c1, c2, ... cn), ci = f(va, vb, T), where S represents the skin drug delivery scheme for the current disease, ci represents the skin drug delivery scheme (including drug delivery site, drug, and drug delivery control parameters) at different drug delivery sites when controlling drug delivery for the disease, va and vb are the control parameters of the first and second pressure units in the drug delivery unit, respectively, and T is the control parameter of the temperature unit in the drug delivery unit. By controlling va, vb, and T in each drug delivery unit, the drug delivery pressure difference in the drug delivery unit is controlled, providing the power for drug penetration through the skin.

[0083] In one optional embodiment of this application, the drug delivery unit includes a direct drug delivery unit and an auxiliary drug delivery unit. The direct drug delivery unit is provided with a direct drug delivery pressure unit and a temperature unit, and the auxiliary drug delivery unit is provided with an auxiliary drug delivery pressure unit. The auxiliary drug delivery pressure unit is used to control the auxiliary drug delivery unit to generate a first pressure, so as to fix the drug delivery unit to the skin and form a sealed drug delivery area. The direct drug delivery pressure unit is used to control the direct drug delivery unit to generate a second pressure, and the temperature unit controls the direct drug delivery unit to generate a drug delivery temperature. The first pressure, the second pressure, and the drug delivery temperature control the generation of a pressure difference within the sealed drug delivery area formed by the drug delivery unit and the skin to control drug penetration through the skin for drug delivery.

[0084] The pressure difference for skin administration is controlled using pressure and temperature control parameters. This includes: determining a drug administration control model corresponding to the drug administration control characteristic data; controlling the pressure and temperature of the drug administration device when it comes into contact with the skin according to the drug administration control model; detecting the pressure difference in the drug administration area using a pressure difference detection element in the drug administration device; determining whether the pressure difference data meets the drug administration pressure difference range corresponding to the drug administration control model; if not, the drug administration control model generates pressure adjustment parameters and temperature adjustment parameters based on the currently detected pressure difference data; adjusting the pressure using the pressure adjustment parameters; and adjusting the temperature using the temperature adjustment parameters. By monitoring the pressure difference during drug administration and adjusting the temperature difference based on the monitored pressure difference data using the drug administration control model, the temperature difference in the drug administration area is controlled within the preset drug administration pressure difference range for skin administration. By using a pressure difference detection element in the drug administration device for feedback control during drug administration, and by comparing the detected pressure difference data with the preset drug administration pressure difference range, temperature and pressure are controlled during drug administration, thereby controlling the drug administration pressure difference. The pressure difference forms the driving force for the drug to penetrate the skin and act on the lesion site, improving drug administration efficiency.

[0085] In another optional embodiment of this application, a skin drug delivery control method is provided. The method includes: identifying drug delivery characteristic data to obtain first drug delivery characteristic data and second drug delivery characteristic data, wherein the first drug delivery characteristic data is drug delivery characteristic data used to control a first drug delivery unit to perform skin drug delivery, and the second drug delivery characteristic data is drug delivery characteristic data used to control a second drug delivery unit to perform skin drug delivery; identifying the first drug delivery characteristic data to obtain a first drug delivery meridian location; identifying the second drug delivery characteristic data to obtain a second drug delivery meridian location; controlling the first drug delivery unit to provide the power for drug penetration through the skin at the first drug delivery meridian location based on the first drug delivery characteristic data; and controlling the second drug delivery unit to provide the power for drug penetration through the skin at the second drug delivery meridian location based on the second drug delivery characteristic data.

[0086] For example, in the treatment of ascites, medication is administered at the bilateral liver acupoints and bilateral kidney acupoints based on drug administration characteristic data. The medication is a blood-activating and stasis-removing drug. The bilateral kidney acupoints belong to the Bladder Meridian of Foot Taiyang. The kidneys regulate the body's water metabolism, thus maintaining normal bodily functions. If the kidneys' function of governing water is disordered, problems such as water retention, difficulty urinating, urinary incontinence, and edema can easily occur. The bilateral liver acupoints, also belonging to the Bladder Meridian of Foot Taiyang, are where the dampness and wind qi of the liver are transported to the Bladder Meridian, having the effects of soothing the liver and gallbladder, regulating qi, and improving eyesight. The first drug administration unit administers the medication at the bilateral liver acupoints, and the second drug administration unit administers the medication at the bilateral kidney acupoints. The first and second drug administration units, located at the bilateral liver and kidney acupoints respectively, provide the power for the medication to penetrate the skin. By controlling the drug administration pressure and temperature parameters in the first and second drug administration units, the pressure difference in the drug administration area can be controlled.

[0087] For example, in the treatment of facial paralysis, based on drug administration characteristic data, medication is administered at the Dazhui (GV14) and Lingtai (GV10) acupoints. The medication is a blood-activating and stasis-removing drug. Dazhui is the meeting point of the Du meridian and the three Yang meridians of the hand and foot, connecting to the brain and having the function of governing all Yang, with the effects of relieving exterior symptoms, promoting Yang, clearing the brain, and calming the mind. Lingtai, belonging to the Du meridian, has the effect of tonifying Qi and replenishing Yang. The first drug administration unit administers the medication at the Dazhui acupoint, and the second drug administration unit administers the medication at the Lingtai acupoint. The first and second drug administration units, located at the Dazhui and Lingtai acupoints respectively, provide the power for the medication to penetrate the skin. By controlling the drug administration pressure and temperature parameters in the first and second drug administration units, the pressure difference in the drug administration area can be controlled.

[0088] In another optional embodiment of this application, a drug delivery device for skin drug delivery is provided. The drug delivery device may be provided with one drug delivery unit or multiple drug delivery units. When the drug delivery unit is performing drug delivery, each drug delivery unit can be controlled individually or as a whole. The drug delivery pressure difference in the drug delivery unit can be controlled, including controlling the drug delivery time, pressure, temperature, etc. The drug delivery unit is connected to a cloud platform to realize information interaction with the cloud platform.

[0089] Figure 4 This is a schematic diagram of the structure of a skin drug delivery control device provided in this application, as shown below. Figure 4 As shown, the device includes:

[0090] The disease identification module 41 is used to identify the disease characteristic data for drug administration, wherein the disease characteristic data for drug administration is characteristic data used to represent the disease to be treated by the drug;

[0091] The drug administration determination module 42 determines drug administration characteristic data based on the disease characteristic data. The drug administration characteristic data includes drug administration meridian location characteristic data and drug administration data, so that the drug administration is carried out through the meridian between the drug administration meridian location and the location corresponding to the disease to be treated.

[0092] The drug delivery control module 43 controls the drug delivery unit to provide the power for drug penetration and skin delivery at the drug delivery meridian location based on drug delivery characteristic data.

[0093] Figure 5 A schematic diagram of another skin drug delivery control device provided in this application is shown below. Figure 5 As shown, the device includes:

[0094] The disease identification module 51 is used to identify the characteristic data of the disease to be treated and obtain the meridian characteristic data of the drug administration. The meridian characteristic data of the drug administration is the meridian data used to represent the disease to be treated by the drug administration.

[0095] The drug delivery location determination module 52 is used to determine the drug delivery meridian location feature data based on the drug delivery meridian feature data, wherein the drug delivery meridian location feature data is data used to represent the drug delivery location;

[0096] The drug determination module 53 is used to match the drug data corresponding to the disease characteristic data in a preset drug administration database, wherein the drug data is data representing the drug to be administered; and

[0097] The drug administration feature determination module 54 is used to process the drug administration meridian location feature data and drug administration data to generate drug administration feature data.

[0098] The specific methods of execution of each unit in the above embodiments have been described in detail in the embodiments of the method, and will not be elaborated here.

[0099] In summary, this application achieves external treatment of internal diseases by controlling drug delivery through non-invasive skin penetration. It determines disease characteristic data, and based on this disease characteristic data, determines drug delivery characteristic data including meridian location characteristics and drug data. The drug delivery unit is then controlled to provide the power for drug penetration at the meridian location. By determining the skin delivery location and drug based on the disease to be treated, the inaccuracy of drug delivery in existing technologies is solved, achieving improved drug delivery accuracy and efficiency.

[0100] It should be noted that the steps shown in the flowchart in the accompanying drawings can be executed in a computer system such as a set of computer-executable instructions, and although a logical order is shown in the flowchart, in some cases the steps shown or described may be executed in a different order than that shown here.

[0101] Obviously, those skilled in the art should understand that the various units or steps of this application described above can be implemented using general-purpose computing devices. They can be centralized on a single computing device or distributed across a network of multiple computing devices. Optionally, they can be implemented using computer-executable program code, thereby storing them in a storage device for execution by a computing device, or fabricating them separately as individual integrated circuit modules, or fabricating multiple modules or steps into a single integrated circuit module. Thus, this application is not limited to any particular combination of hardware and software.

[0102] The above description is merely a preferred embodiment of this application and is not intended to limit this application. Various modifications and variations can be made to this application by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of this application should be included within the protection scope of this application.

Claims

1. A drug delivery control device for treating internal diseases externally, characterized in that, This drug delivery control device is used to control the administration of drugs in a non-invasive, skin-penetrating manner to achieve external treatment of internal diseases. It is applied in a drug delivery device equipped with a drug delivery unit, and includes: The disease identification module is used to identify the disease characteristics data for drug administration, wherein the disease characteristics data are characteristic data used to represent the disease to be treated by the drug administration. The drug administration determination module determines drug administration characteristic data based on the disease characteristic data, wherein the drug administration characteristic data includes drug administration meridian location characteristic data and drug administration data, so that the drug is administered through the meridian between the drug administration meridian location and the location corresponding to the disease to be treated; and The drug delivery control module controls the drug delivery unit to provide the power for drug penetration and skin delivery at the drug delivery meridian location based on the drug delivery characteristic data; The drug delivery unit includes a direct drug delivery unit and an auxiliary drug delivery unit. The direct drug delivery unit is equipped with a direct drug delivery pressure unit and a temperature unit, while the auxiliary drug delivery unit is equipped with an auxiliary drug delivery pressure unit. The auxiliary drug delivery pressure unit is used to control the auxiliary drug delivery unit to generate a first pressure, thereby fixing the drug delivery unit to the skin and forming a sealed drug delivery area. The direct drug delivery pressure unit is used to control the direct drug delivery unit to generate a second pressure, and the temperature unit controls the direct drug delivery unit to generate a drug delivery temperature. By controlling the first pressure, the second pressure, and the drug delivery temperature, a pressure difference is generated within the sealed drug delivery area formed by the drug delivery unit and the skin to control drug penetration through the skin for drug delivery. The drug administration determination module determines drug administration characteristic data based on the disease characteristic data, including: Determining drug administration characteristic data based on the drug administration disease characteristic data includes: traversing a preset meridian drug administration database, determining whether drug administration meridian characteristic data corresponding to the drug administration disease characteristic data exists in the preset meridian drug administration database; if it exists, obtaining the drug administration meridian characteristic data; if it does not exist, identifying the drug administration disease characteristic data to obtain a disease-specific MRI image, wherein the disease-specific MRI image is an MRI image used to represent the disease to be treated by the drug; and performing meridian feature extraction processing based on image segmentation and recognition on the disease-specific MRI image to obtain the drug administration meridian characteristic data. The expression for the scheme of treating internal diseases externally through skin administration is: S=c(c1, c2, ..., cn), ci=f(va, vb, T), where S represents the drug administration characteristic data of the disease, ci represents the drug administration characteristic data at different drug administration locations when controlling the drug administration of the disease, and the drug administration characteristic data includes the drug administration meridian location characteristic data, the drug administration data, and drug administration control parameters, va is the control parameter of the first pressure unit in the drug administration unit, vb is the control parameter of the second pressure unit in the drug administration unit, and T is the control parameter of the temperature unit in the drug administration unit. By controlling va, vb, and T in the drug administration unit, the drug administration pressure difference in the drug administration unit is controlled, providing the power for drug penetration through the skin for drug administration.

2. The drug delivery control device according to claim 1, characterized in that, The dosing determination module includes: The disease identification module is used to identify the disease characteristic data of the drug administration and obtain the drug administration meridian characteristic data, wherein the drug administration meridian characteristic data is the meridian data used to represent the treatment of the disease to be treated; The drug administration location determination module is used to determine drug administration meridian location feature data based on the drug administration meridian feature data, wherein the drug administration meridian location feature data is data used to represent the drug administration location; A drug determination module is used to match drug data corresponding to the disease characteristic data in a preset drug administration database, wherein the drug data is data representing the drug to be administered; and The drug administration feature determination module is used to perform drug administration feature generation processing on the drug administration meridian location feature data and the drug administration data to obtain the drug administration feature data.

3. The drug delivery control device according to claim 1, characterized in that, The controlled drug delivery module includes: The drug administration feature recognition module is used to identify the drug administration feature data to obtain the drug administration meridian location feature data and the drug administration data; A drug delivery feature matching module is used to match drug delivery control feature data corresponding to the drug delivery meridian location feature data and the drug delivery data in a preset drug delivery database. The drug delivery control feature data represents the dynamics of controlling drug penetration through the skin for transdermal drug delivery. The drug delivery feature control module is used to control the drug delivery unit to fix itself to the skin and provide the power for drug to penetrate the skin for drug delivery at the drug delivery meridian location corresponding to the drug delivery meridian location feature data.

4. The drug delivery control device according to claim 3, characterized in that, The drug delivery characteristic control module includes: A parameter determination module is used to determine drug delivery control parameters for skin drug delivery based on the drug delivery control characteristic data, wherein the control parameters include a first control parameter and a second control parameter, one of the first control parameter and the second control parameter is a pressure control parameter, and the other of the first control parameter and the second control parameter is a temperature control parameter; and The pressure difference control module is used to control the pressure difference for skin drug delivery through the pressure control parameters and the temperature control parameters, wherein the pressure difference is the pressure difference for drug delivery through the skin.

5. The drug delivery control device according to claim 1, characterized in that, The drug delivery device includes a first drug delivery unit and a second drug delivery unit. Controlling the drug delivery unit to provide the power for drug penetration and transdermal drug delivery at the drug delivery meridian location based on the drug delivery characteristic data includes: The drug administration characteristic data is identified to obtain first drug administration characteristic data and second drug administration characteristic data, wherein the first drug administration characteristic data is drug administration characteristic data used to control the first drug administration unit to perform skin drug administration, and the second drug administration characteristic data is drug administration characteristic data used to control the second drug administration unit to perform skin drug administration; The location of the first drug administration meridian is obtained by identifying the first drug administration characteristic data; The second drug administration characteristic data is identified to obtain the location of the second drug administration meridian; Based on the first drug delivery characteristic data, the first drug delivery unit is controlled to provide the power for drug penetration and skin delivery at the first drug delivery meridian location; and Based on the second drug delivery characteristic data, the second drug delivery unit is controlled to provide the power for drug penetration and skin delivery at the second drug delivery meridian location.

6. A computer-readable storage medium, characterized in that, The computer-readable storage medium stores computer instructions for causing the computer to perform a skin drug delivery control method, the skin drug delivery control method comprising: Determine the disease characteristic data for drug administration, wherein the disease characteristic data for drug administration is characteristic data used to represent the disease to be treated by the drug; Based on the disease-specific characteristic data, drug administration characteristic data is determined, wherein the drug administration characteristic data includes drug administration meridian location characteristic data and drug administration data, so that the drug is administered through the meridian between the drug administration meridian location and the location corresponding to the disease to be treated; and Based on the drug delivery characteristic data, the drug delivery unit is controlled to provide the power for drug penetration and skin delivery at the drug delivery meridian location; The drug delivery unit includes a direct drug delivery unit and an auxiliary drug delivery unit. The direct drug delivery unit is equipped with a direct drug delivery pressure unit and a temperature unit, while the auxiliary drug delivery unit is equipped with an auxiliary drug delivery pressure unit. The auxiliary drug delivery pressure unit is used to control the auxiliary drug delivery unit to generate a first pressure, thereby fixing the drug delivery unit to the skin and forming a sealed drug delivery area. The direct drug delivery pressure unit is used to control the direct drug delivery unit to generate a second pressure, and the temperature unit controls the direct drug delivery unit to generate a drug delivery temperature. By controlling the first pressure, the second pressure, and the drug delivery temperature, a pressure difference is generated within the sealed drug delivery area formed by the drug delivery unit and the skin to control drug penetration through the skin for drug delivery. The drug administration determination module determines drug administration characteristic data based on the disease characteristic data, including: Determining drug administration characteristic data based on the drug administration disease characteristic data includes: traversing a preset meridian drug administration database, determining whether drug administration meridian characteristic data corresponding to the drug administration disease characteristic data exists in the preset meridian drug administration database; if it exists, obtaining the drug administration meridian characteristic data; if it does not exist, identifying the drug administration disease characteristic data to obtain a disease-specific MRI image, wherein the disease-specific MRI image is an MRI image used to represent the disease to be treated by the drug; and performing meridian feature extraction processing based on image segmentation and recognition on the disease-specific MRI image to obtain the drug administration meridian characteristic data. The expression for the scheme of treating internal diseases externally through skin administration is: S=c(c1, c2, ..., cn), ci=f(va, vb, T), where S represents the drug administration characteristic data of the disease, ci represents the drug administration characteristic data at different drug administration locations when controlling the drug administration of the disease, and the drug administration characteristic data includes the drug administration meridian location characteristic data, the drug administration data, and drug administration control parameters, va is the control parameter of the first pressure unit in the drug administration unit, vb is the control parameter of the second pressure unit in the drug administration unit, and T is the control parameter of the temperature unit in the drug administration unit. By controlling va, vb, and T in the drug administration unit, the drug administration pressure difference in the drug administration unit is controlled, providing the power for drug penetration through the skin for drug administration.

7. An electronic device, characterized in that, include: At least one processor; and a memory communicatively connected to the at least one processor; wherein the memory stores a computer program executable by the at least one processor, the computer program being executed by the at least one processor to cause the at least one processor to perform a skin drug delivery control method, the method comprising: Determine the disease characteristic data for drug administration, wherein the disease characteristic data for drug administration is characteristic data used to represent the disease to be treated by the drug; Based on the disease-specific characteristic data, drug administration characteristic data is determined, wherein the drug administration characteristic data includes drug administration meridian location characteristic data and drug administration data, so that the drug is administered through the meridian between the drug administration meridian location and the location corresponding to the disease to be treated; and Based on the drug delivery characteristic data, the drug delivery unit is controlled to provide the power for drug penetration and skin delivery at the drug delivery meridian location; The drug delivery unit includes a direct drug delivery unit and an auxiliary drug delivery unit. The direct drug delivery unit is equipped with a direct drug delivery pressure unit and a temperature unit, while the auxiliary drug delivery unit is equipped with an auxiliary drug delivery pressure unit. The auxiliary drug delivery pressure unit is used to control the auxiliary drug delivery unit to generate a first pressure, thereby fixing the drug delivery unit to the skin and forming a sealed drug delivery area. The direct drug delivery pressure unit is used to control the direct drug delivery unit to generate a second pressure, and the temperature unit controls the direct drug delivery unit to generate a drug delivery temperature. By controlling the first pressure, the second pressure, and the drug delivery temperature, a pressure difference is generated within the sealed drug delivery area formed by the drug delivery unit and the skin to control drug penetration through the skin for drug delivery. The drug administration determination module determines drug administration characteristic data based on the disease characteristic data, including: Determining drug administration characteristic data based on the drug administration disease characteristic data includes: traversing a preset meridian drug administration database, determining whether drug administration meridian characteristic data corresponding to the drug administration disease characteristic data exists in the preset meridian drug administration database; if it exists, obtaining the drug administration meridian characteristic data; if it does not exist, identifying the drug administration disease characteristic data to obtain a disease-specific MRI image, wherein the disease-specific MRI image is an MRI image used to represent the disease to be treated by the drug; and performing meridian feature extraction processing based on image segmentation and recognition on the disease-specific MRI image to obtain the drug administration meridian characteristic data. The expression for the scheme of treating internal diseases externally through skin administration is: S=c(c1, c2, ..., cn), ci=f(va, vb, T), where S represents the drug administration characteristic data of the disease, ci represents the drug administration characteristic data at different drug administration locations when controlling the drug administration of the disease, and the drug administration characteristic data includes the drug administration meridian location characteristic data, the drug administration data, and drug administration control parameters, va is the control parameter of the first pressure unit in the drug administration unit, vb is the control parameter of the second pressure unit in the drug administration unit, and T is the control parameter of the temperature unit in the drug administration unit. By controlling va, vb, and T in the drug administration unit, the drug administration pressure difference in the drug administration unit is controlled, providing the power for drug penetration through the skin for drug administration.

Images